Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma;Endocrine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01391351
What this trial is testing

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

Who this might be right for
Carcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
Centre Francois Baclesse 107
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Large-scale testing (Phase 3)Study completedNCT03353831
What this trial is testing

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

Who this might be right for
Recurrent Ovarian Carcinoma
AGO Research GmbH 574
Early research (Phase 1)Ended earlyNCT00303888
What this trial is testing

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Yale University 31
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Testing effectiveness (Phase 2)Study completedNCT00837031
What this trial is testing

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Who this might be right for
Metastatic Pancreatic Cancer
SCRI Development Innovations, LLC 72
Testing effectiveness (Phase 2)Looking for participantsNCT06486883
What this trial is testing

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

Who this might be right for
Advanced Breast CancerAdvanced Breast CarcinomaHormone Receptor Positive Breast Carcinoma
MedSIR 200
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Testing effectiveness (Phase 2)Looking for participantsNCT04519151
What this trial is testing

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsCarcinoma, Ovarian EpithelialNeoplasm of Stomach+5 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableNot Yet RecruitingNCT07826780
What this trial is testing

The STRONG Nutrition Support Study for People With Pancreatic Cancer

Who this might be right for
Pancreas Cancer, MetastaticPancreas Carcinoma
UNC Lineberger Comprehensive Cancer Center 80
Not applicableStudy completedNCT04546373
What this trial is testing

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Grupo Español de Investigación en Cáncer de Ovario 316
Testing effectiveness (Phase 2)Study completedNCT01519869
What this trial is testing

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

Who this might be right for
Primary Peritoneal CarcinomaOvarian CarcinomaFallopian Tube Carcinoma
Rachel Miller 28
Early research (Phase 1)Active Not RecruitingNCT01970722
What this trial is testing

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Who this might be right for
FIGO Stage IVA Ovarian CancerFIGO Stage IVB Ovarian CancerPlatinum-Resistant Ovarian Carcinoma+26 more
City of Hope Medical Center 40
Large-scale testing (Phase 3)Ended earlyNCT00003880
What this trial is testing

Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Merck Sharp & Dohme LLC 132
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Next Page